secwatch.observer — SEC 8-K summary
======================================

Issuer:     INFINITY PHARMACEUTICALS, INC. (—)
CIK:        0001113148
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001140361-22-047653
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Infinity Pharma receives Nasdaq delisting notice for bid price below $1.00
--------------------------------------------------------------------------

- Nasdaq letter received Dec 28, 2022; common stock bid price under $1.00 for 30 consecutive days.
- Company has 180 calendar days, until June 26, 2023, to regain compliance.
- Compliance requires closing bid price of $1.00+ for 10 consecutive business days.
- If not cured, may transfer to Nasdaq Capital Market for an additional 180-day period.
- Management will monitor bid price and evaluate options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1113148/000114036122047653/0001140361-22-047653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1113148/000114036122047653/brhc10046105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-047653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer